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Regulating the Immune Review
Response to Transplants:
A Role for CD41 Regulatory Cells?
ing came at a time when the notion of T cell–mediated
suppression was in disrepute with claims that T suppres-
sors were within the CD8 subset of complex regulatory
circuits; a role for I–J, antigen-specific suppressor-fac-
tors; and a host of other irreconcilable claims.
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Sir William Dunn School of Pathology
University of Oxford
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United Kingdom The existence of CD41 T cells that could suppress
graft rejection in mice was shown in 1993 (Qin et al.).
Transplantation tolerance induced in mice, using a short
pulse of nondepleting antibody therapy with anti-mouseIntroduction
CD4 and CD8, was associated with CD41 T cells thatTransplantation of cells and organs is now a rapidly
could, on adoptive transfer, suppress graft rejection byevolving therapeutic modality for the correction of a
naive T cells. Although these initial studies were con-wide range of disease states. This has been made pos-
ducted with skin grafts mismatched for multiple minorsible by the development of powerful immunosuppres-
transplantation antigens, CD41 regulatory T cells weresant drugs that can stave off the rejection process.
also found in mice tolerating heart grafts mismatchedHowever, these drugs usually require lifelong adminis-
across the whole MHC (Chen et al., 1996). Since then,tration, patient compliance, and risk a wide range of un-
the demonstration of CD41 regulatory or suppressorwanted side effects, including susceptibility to infec-
T cells in a wide range of models of transplantation tol-tions and cancer. Ideally, one would like to avoid these
erance in rodents (Yin and Fathman, 1995; Davies et al.,complications by induction of “operational tolerance”
1996a; Waldmann and Cobbold, 1998, 2000; Zhai andto the transplant. The term operational tolerance is care-
Kupiec-Weglinski, 1999) makes their existence nowfully chosen, as any such acquired tolerant state need
indisputable (Table 1).not reflect the same hierarchy of mechanisms that the
Nevertheless, knowledge of the characteristics of theseimmune system normally uses to ensure self-tolerance
cells is limited as compared to other types of CD41but, rather, any among those that enable the trans-
T cells. There are probably four main reasons why. First,planted organ to function without being the target of a
there is the element of overactive yet unjustifieddestructive immunological attack.
scepticism that has potentially limited the number ofThe pioneering experiments of Medawar and his col-
researchers entering the field of suppression. Second,leagues, who injected donor marrow into newborn mice,
there is yet no consensus in vitro readout that correlatesdemonstrated the point that tolerance could be ac-
with the in vivo function (Cobbold et al., 1996). Third,quired. Numerous studies that followed suggested that
suppressive CD41 clones have never been grown fromthe hematopoietic macrochimerism that accompanied
tolerant animals. (Clonal suppressors would enablethe tolerant state was often associated with “deletional”
proper analysis of differentially expressed gene prod-tolerance, where alloreactive T cells were continuously
ucts.) Fourth, the in vivo readout (i.e., suppression of apurged from the repertoire.
rejection process) is itself a challenging one in terms ofIt is not surprising, therefore, that many groups have
the time-to-end point and quantitation of the sup-targeted their tolerance-inducing strategies toward en-
pressive effect.suring macrochimerism of donor marrow, with the rea-
Consequently, much of what we currently know aboutsonable justification that, if attainable, this would repre-
the immunobiology of regulatory T cells (hereafter calledsent a robust form of tolerance. However, the logistic
T-regs) in transplantation derives from one particularissues related to achieving tolerance in this manner have
model of transplantation tolerance—that induced withencouraged others to attempt to establish tolerance to
a short pulse of CD4 antibodies (reviewed in Waldmannthe organ itself, without the need for intermediary mar-
and Cobbold, 1998). The information gained providesrow stem cells. It is within this framework that evidence
us with a set of parameters that will need to be accountedfor the existence of powerful regulatory CD41 T cells has
for in any comprehensive explanation of how these cellsemerged. This review will outline what we know about
work. Their main features are summarized below.these cells, and it will consider the relationship, if any,
Targets of Suppressionwith regulatory T cells involved in the prevention of auto-
Although these regulatory T cells are CD41, they areimmune diseases and inflammatory bowel disease (IBD).
able to suppress rejection by both naive and primed
CD41 or CD81 T cells (Marshall et al., 1996).CD41 Regulatory T Cells in Transplantation Tolerance
Duration of the Induction PeriodThe first description of CD41 T cells mediating suppres-
It may take many weeks after CD4 antibody therapy ission in transplantation tolerance came from the work of
initiated for these regulatory T cells to become apparentHall et al. (1985), who were analyzing why they obtained
in functional readouts (Scully et al., 1994; Saitovitch etprolonged cardiac allograft survival in rats after a brief
al., 1996). This suggests either that T-regs need to clon-period of treatment with cyclosporine A (CyA). This find-
ally expand and/or that their presence is masked by the
activity of other T cells that remain competent to reject,
such effectors being gradually inactivated or eliminated* To whom correspondence should be addressed (e-mail: herman.
waldmann@path.ox.ac.uk). over time.
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Table 1. Therapeutic Reagents for Tolerance Therapy
Antibody Specificity Successes Failures T Cell–Mediated Regulation?
CD4 1 CD8 (nondepleting) MHC-mismatched skin black background mice infectious tolerance
CD40L 1 hCTLA-4-Ig MHC-mismatched skin mCTLA-4-Ig cyclosporin interferes
CD40L 1 CD8 depletion minors skin grafts MHC-mismatched skin infectious tolerance
CD3 (nonmitogenic) minors skin grafts MHC-mismatched skin suppression
CD4 (nondepleting) alone MHC-mismatched heart MHC or minors mm skin infectious tolerance
CD3 diabetes in NOD mouse minors skin grafts suppression
CD4 (low-dose depletion) MHC-mismatched heart minors skin grafts infectious tolerance
hCTLA-4-Ig MHC-mismatched heart minors skin grafts infectious tolerance
CD28 alone heart grafts, NOD mouse minors skin grafts
B7.1 1 B7.2 HGG, SRBC response minors skin grafts
CD2 (CD2R) neonatal/xeno heart grafts minors skin grafts suppression
CD25 heart grafts minors skin grafts
Relative potency in mouse models (most potent at the top).
Dependence on Continuous Antigen where new cohorts of suppressor cells arise. This finding
of infectious tolerance offers an explanation of howThe regulators are highly dependent on a continuous
grafts may be maintained long term in their hosts evensupply of antigen. If tolerant cells are parked in T cell–
with continuous emergence of new alloreactive T cellsdeprived recipients, they rapidly lose the ability to sup-
from the thymus. Infectious tolerance has also beenpress unless further antigen is provided (Scully et al.,
described where tolerance has been induced using1994; Cobbold et al., 1996; Chen et al., 1996)
short pulses of anti-CD40L antibody (Graca et al., 2000).Antigen Specificity and Linked Suppression
Possible mechanisms are shown in Figure 2.Although these cells show specificity to the antigen that
Are T-regs Necessary for Toleranceinduced them, they seem able to extend their influence
and Not Just a By-Product?to suppress rejection directed to other antigens if these
T-regs are necessary for the tolerant state to be main-are located in the same tissue. In other words, if an
tained. There are clear examples where ablation of CD41A-type animal is tolerant of B, then it will often accept
T cells in tolerized animals has been shown to result ingrafts from (B 3 C)F1 donors (Figure1). This can be
the loss of the tolerant state. In those cases, rejectionconsidered a form of “linked suppression” (Davies et al.,
was mediated by CD81 T cells now freed from restraint1996b; Chen et al., 1996; Wong et al., 1997; Bemelman et
by the tolerant CD41 T cells (Marshall et al., 1996). Thisal., 1998; Honey et al., 1999). Over time, animals become
outcome is probably a reflection of the fact that thetolerant to C-type grafts. Cell transfer studies have con-
infectious tolerance process, whereby tolerant cells be-firmed that CD41 T-regs are responsible for this effect
get more tolerant cells, is only confined to the CD41(Chen et al., 1996). Clear evidence also exists to show
compartment. The behavior of CD81 T cells is deter-that T-regs, just like any other CD41 T cells, recognize
mined by the extent to which they are suppressed andtheir target antigens for suppression after they have
the extent to which they have undergone activation-been processed/reprocessed and presented on host-
induced cell death (AICD). In other words, the two majortype antigen-presenting cells (APC), in other words,
T cell compartments are behaving in different waysthrough indirect presentation (Wise et al., 1998).
when tolerance is induced. Some CD41 T cells becomeThis all means that the influence of T-regs in suppres-
anergic, some become regulators, and, perhaps, others
sion must be at a local rather than systemic level (Figure
undergo deletion. Within the CD81 population, many
2). Such possible locations could be at the inductive
graft-reactive cells probably undergo AICD, as shown
end in the microenvironment of the APC or at the effector by Wells et al. (1999), while others may come under the
end in the transplant itself or indeed both sites. If the restraining influence of CD41 regulators.
latter, then it should be possible to show enrichment of There Are Many Ways of Generating Tolerance
T-regs in the target organ. T-reg enrichment has indeed Dependent on CD41 Regulation
been described for renal allografts (Zhai and Kupiec- The generation of CD41 regulatory cells is probably a
Weglinski, 1999). general feature of any circumstance where tolerance
Tolerance Is Infectious has been induced to transplanted tissues without mac-
By using genetically marked cell populations, it has been rochimerism. CD41 regulatory T cells have now been
possible to show that, not only do the CD41 regulatory demonstrated in tolerance induced with other antibod-
cells suppress naive T cells, but, in the presence of the ies (CD4, CD3, CD2, and CD154) and a range of different
transplanted tissue, they can also guide naive cells into drugs (reviewed in Waldmann and Cobbold, 2000; Hall,
a state of tolerance (Figure 1). This second-generation 2000). Tolerance induced to low doses of bone marrow is
tolerance imposed on the naive population is also of a also dependent on infectious tolerance, unlike tolerance
dominant, suppressive type, as CD41 T cells from this induced with high doses of marrow with macrochime-
source can now suppress rejection of further cohorts rism, where tolerance seems largely deletional (Bemel-
of naive T cells (Qin et al., 1993; Chen et al., 1996; Ono- man et al., 1998).
dera et al., 1996; Bemelman et al., 1998; Cobbold and Some Therapeutic Agents May Interfere with
Waldmann, 1998). “Infectious tolerance,” once initiated, the Generation and Function of T-regs
can operate over several generations of naive recipients, Tolerance associated with regulatory T cells can be seen
in some circumstances where rejection is prevented,converting the T cells of each into the tolerant state
Review
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Figure 1. Experimental Model to Demonstrate Linked Suppression and Infectious Tolerance Mediated by T Cells from Tolerized Mice
CBA/Ca mice (H-2k) were rendered tolerant to C57Bl/10 (B10) heart grafts (H-2b), using a nondepleting protocol of a cocktail of CD4 and CD8
antibodies. All heart grafts were accepted. Spleen cells from such mice taken 100 days after transplantation can, on transfer to naive mice,
stop their immune system from rejecting a B10 heart and even a heart graft from (B10 3 BALB/c)F1 donors (i.e., H-2b 3 H-2d)F1. Spleen cells
from mice that had accepted (B10 3 BALB/c)F1 hearts by linked suppression could then transfer the capacity to accept the third-party
BALB/C (H-2d) hearts onto naive mice.
T cell transfers from tolerant mice could be repeated over nine generations of hosts, and, with the use of genetic markers (Th1.1 and Th1.2),
it could be established that the capacity to suppress had transferred from donor T cells to recipient T cells (infectious tolerance). Adapted
from Chen et al. (1996).
but not in all. For example, although tolerance can be yet discern whether suppression acts to block T cell
proliferation or whether it works in a more downstreaminduced with CD4 antibodies, concomitant administra-
tion of CyA can prevent it (Hamano et al., 1997). This way, affecting competence of T cells to do damage.
The Development and Function of T-regs Are Noteither means that the induction of T-reg is sensitive to
CyA and/or that CyA prevents activation-induced cell Amenable to Blockade by Anti-CD4 Antibodies
Surprisingly, neither the induction nor the maintenancedeath of antigen-reactive rejector cells as suggested by
Turka and Strom (Wells et al., 1999). They would argue of T-regs can be inhibited by nondepleting CD4 antibod-
ies (Scully et al., 1994; Marshall et al., 1996), even thoughthat, in the face of a reduced mass of alloreactive T cells,
T-regs may have a better chance of emerging as the such antibodies are potent at blocking conventional
CD4 T cell functions. In contrast, ablative CD4 antibod-functionally dominant set.
There Are No Compelling In Vitro Correlates ies eliminate T-regs. This suggests that T-regs may not
need functional interactions of CD4 with MHC class IIfor the T-regs of Transplantation Tolerance
Even though tolerance through regulation can be a pow- and that possibly they use some other accessory mole-
cule to interact with APC.erful process in vivo, conventional in vitro assays using
splenocytes have not demonstrated any substantive The Potential to Regulate the Rejection of Transplanted
Tissue Preexists in Recipients before Any Exposureloss of mixed lymphocyte response (MLR) nor major
profound changes in cytokine activity (Cobbold et al., to a Transplant or Therapeutic Maneuver
Davies et al. (1999) observed that naive CD41CD45RBlo1996). In only one case, where tolerance had been in-
duced to low-dose donor marrow with demonstrable cells were able to suppress naive T cells from rejecting
grafts in an adoptive transfer model. We need to be ablemicrochimerism, was there evidence of in vitro “anergy”
(Qin et al., 1989). We first proposed the “civil service” to explain how this can be. It suggests that T-regs are
not solely the outcome of therapeutic maneuvers to getconcept in an attempt to explain how anergic T cells might
coexist with regulatory T cells (Figure 3). We suggested tolerance but that recipients already have cells poised
to act in this way.that anergic T cells might themselves be the elusive
T-regs acting in a subversive, perhaps passive, manner Regulatory CD41 T Cells in Controlling
Other Immune Functionsto block the function of their able compatriots (Wald-
mann et al., 1992). Unfortunately, there is still no data While the transplant field has been grappling with sup-
pression by CD41 T cells, CD41 T-regs have also beenavailable in tolerized mice on the proliferative capacity
of antigen-specific T cells in vivo. Therefore, we cannot documented as cells that can prevent the onset of auto-
Immunity
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Figure 2. Mechanisms of Linked Suppression and Infectious Tolerance
The profound immune regulation associated with peripheral tolerance in vivo is associated with two closely related phenomena that are both
dependent on CD41 T cells: linked suppression and infectious tolerance. Linked suppression can be demonstrated in mice made specifically
tolerant to a first set of graft antigens by using, for example, nondepleting CD4 monoclonal antibodies. Such mice will accept fresh grafts
from the tolerizing strain and reject third-party grafts, demonstrating antigen specificity for the regulatory CD41 T cells. However, certain
third-party antigens that are rejected when grafted from parental donors are accepted if presented on the same antigen-presenting cells
(APCs) as the tolerated antigens on a graft from an F1 cross between the two donor strains. This linked suppression of third-party rejection
can be observed in the original tolerized animal or by adoptive transfer of purified CD41 T cells to appropriate recipients. Continuous linked
suppression alone could account for indefinite survival of such third-party antigen-expressing grafts, but it can be shown that the nontolerant
population can themselves generate tolerant, regulatory CD41 T cells against both the original and third-party antigens. These secondary
tolerant T cells can then further propogate the process of linked suppression, generating the phenomenon of infectious tolerance. The
molecular interactions critical to both linked suppression and infectious tolerance are not currently known, but T cell interactions through
cytokines and competition for antigen-presenting cells are likely to be important components. A critical element may also be that T-regs
ensure that the APC with which they interact are always maintained in an incapacitated state, unable to drive T cell immune effector functions.
immune disease (Flynn and Kong, 1991; Fowell and Ma- negative selection, and the generation of regulatory
T cells as a lineage in their own right (Itoh et al., 1999;son, 1993; Sakaguchi et al., 1995; Herbelin et al., 1998;
Mason and Powrie, 1998; Sakaguchi, 2000) and of IBD Sakaguchi, 2000; Seddon and Mason, 2000).
There is at this stage no information on whether these(Powrie et al., 1993; Groux et al., 1997; Groux and Pow-
rie, 1999) and determining oral antigen-induced toler- different regulatory phenomena in the different systems
reside in a defined CD4 T cell subset. Even if one exam-ance in autoimmune models (Weiner et al., 1994). In the
IBD model, cells with regulatory properties have been ines the data for roles for cytokines, then some models
of transplantation tolerance suppression show a role forcloned and coined T regulatory 1 (Tr1) cells (Groux et
al., 1997, Groux and Powrie, 1999). Yet others have been IL-4, while others do not (Davies et al., 1996b; Plain et
al., 1997; Cobbold and Waldmann, 1998; Hall et al., 1998;described as cells that can inhibit in vitro proliferation
of naive T cells (Maeda et al., 2000; Shevach, 2000). A Bushell et al., 1999; Zhai and Kupiec-Weglinski, 1999;
Ke et al., 2000). In oral tolerance, a role for TGF-b hascommon feature of the T cells in all of these systems is
that most of the cells express the IL-2R a chain, a prop- been implicated in protection against experimental aller-
gic encephalomyelitis (EAE) (Weiner et al., 1994). In theerty shared in common with regulatory cells of trans-
plantation (Hall et al., 1990), and, where studied, most IBD models, the case has been made for the involvement
of IL-10 and TGF-b (Powrie et al., 1996; Asseman et al.,exhibit low proliferative potential in vitro.
Currently, there are no unique markers for regulatory 1999), and, in rat diabetes, the case has been made for
IL-4 and TGF-b (Seddon and Mason, 2000) while, incells in any of the systems described. Many of the useful
probes tend to overlap with lymphocyte activation mark- other readouts, none of these cytokines (Thornton and
Shevach, 2000). Rather than consider this as confusing,ers. Nevertheless, application of different combinations
of markers, such as CD45RBlo (mice), CD45RClo (rats), the data may be telling us that regulation may be context
sensitive, selecting from an array of effector mecha-RT6, CD62L, CTLA-4, CD25, CD38, and negativity for 6C10,
do allow enrichment of the regulatory populations for nisms. This should not be surprising. After all, we are
used to the notion of diverse and redundant immunitymore detailed biochemical and genetic analysis. This
may permit comprehensive comparisons of the molecu- mechanisms. Why not so for regulation, a function criti-
cal to the maintenance of self-tolerance?lar fingerprints exhibited by T-regs in the various models,
especially where clones are available. In this way, one Anergic T Cell Lines and Clones as Regulators
In the examples discussed above, regulatory T cellscan establish whether we are dealing with a discrete
subset or diverse cell types. have been isolated in defined conditions of antigen ex-
posure either in vivo or in vitro.In both rat and mouse, there is also evidence for the
existence of T-regs in the thymus, leading to the notion Another approach has been to take antigen-specific
cell lines or cloned populations and render them anergicthat the thymus has three functions: positive selection,
Review
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Figure 3. The Civil Service Model of Tolerance and Suppression
The normal immune response to antigens from infectious organisms depends on collaborative interactions between naive T cells (Nv) and
their “helpful” neighbors focused around specialized APCs, as shown in the top left panel. It is hypothesized that individual naive T cells fail
to get sufficient help, such as cytokines or appropriate costimulatory signals, and that rather than being fully activated they default to a
tolerant state (top right panel). This isolation from help could occur naturally if the antigen-specific naive T cell population is present at too
low a frequency or has insufficient avidity to form a stable cluster, but it is proposed to be analogous to the situation in which the majority
of CD41 T cells have either been depleted or blocked by a therapeutic monoclonal antibody (lower left panel). Once a high proportion of
T cells have defaulted to the tolerant state, they may be able to compete locally for antigen, costimulation, and helpful cytokines, thereby
reinforcing the isolation of any remaining naive T cells or recent thymic emigrants (lower right panel). We have termed this the civil service
hypothesis because the minimum requirement of the tolerant T cells (analogous to government officials) is the ability to passively interfere
with the attempts of naive T cells (analogous to public interest groups) to get a response started.
with, for example, anti-CD3 antibodies and then monitor poorly proliferative CD41CD251 T cell. Certain self-anti-
gens from different tissues may have a greater propen-their ability to suppress proliferative responses in vitro.
This has led to examples where in vitro “anergized” cells sity to provide this sort of stimulation than others. Con-
sequently, T-regs may be more obviously identified forhave been shown to be suppressive to proliferation of
naive T cells or clones (Lombardi et al., 1994; Taams et these antigens than for other self-molecules. Because
of linked suppression, T-regs directed to only a minorityal., 1998). In one case, such in vitro anergized cells, al-
though not derived from a tolerant animal, could sup- of antigens in any tissue may be able to prevent autoim-
mune disease in that tissue. This notion of a minority ofpress graft rejection on in vivo transfer (Chai et al., 1999).
The latter study tells us that T cells anergized artificially self-antigens that maintain regulatory homeostasis to
self has been eloquently argued before, under the ap-can suppress naive T cells in vivo. This then raises the
question of whether viable T cells “naturally” anergized propriate title of the “immune homunculus,” by Cohen
(1992). The select self-antigens, as well as those of theor inactivated in vivo might do the same via a civil ser-
vice–type mechanism (Figure 3). endogenous microbial gut flora, are probably respon-
sible for shaping the repertoire of our natural CD41 reg-Synthesis and Speculation
From all of this information it seems likely that some if ulatory population. These regulatory T cells normally
prevent harmful immune reactions to self-antigens andnot all T cells can be directed to a state where they can
suppress other cells. Although there have been argu- bystander damage resulting from reactions to microbial
mucosa-associated antigens. We are suggesting, then,ments for a dedicated regulatory lineage in the autoim-
mune models (Sakaguchi, 2000; Seddon and Mason, that these CD41 regulatory T cells are not a precommit-
ted lineage but, rather, cells that have had prior and on-2000), the case is not proven. It could simply be that
when a positively selected T cell in the thymus continues going exposure to an “internal antigen.” In the context
of allografts, we would expect this natural repertoire ofto experience and be signaled by self-antigen in the
periphery it can be guided into a regulatory state. Pre- CD41CD251 cells to exhibit cross-reactions with limited
sets of the alloantigens. They could then exert suppres-sumably, this would be limited to antigenic peptides of
low affinity, which could not delete (or negatively select) sion (linked suppression) as observed in the studies of
Davies et al. (1999). The same preexisting population ofthese cells. Such a “chronically stimulated” cell would
be circulating in the periphery and identified as the T-regs would also be available for expansion in thera-
Immunity
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peutic maneuvers that establish transplantation toler-
ance through regulation. The reason that T-regs may not
be detected for many weeks (Scully et al., 1994; Saito-
vitch et al., 1996) could be that this cross-reacting set
(those recognizing internal antigens as well as alloanti-
gen) is so rare that time is needed for them to become
numerically dominant over potential rejector cells. If a
therapeutic maneuver also reduces the size of the ag-
gressive clones (Wells et al., 1999), this would shift the
balance of control to a smaller number of T-regs. Once
this first cohort of T-regs have established control, then
infectious tolerance will recruit other T-regs into the
system. The process then becomes self-sustaining, as
long as antigen is available to drive the T-regs.
Our studies with CD4 antibodies suggest that toleriz-
ing antibodies work by first selectively blindfolding the
T cells so that they cannot damage tissues yet sparing
regulators and the capacity to generate new regulators.
A model of how this might happen is shown in Figures 2
and 3. The work of Turka, Strom, and colleagues sug-
gests that there will also be apoptosis of many antigen-
reactive T cells over time. Eventually, when the thera-
peutic blindfold is removed by withdrawal of antibody
or drug, regulation is in place and dominant.
We could now ask the question whether all types of
CD41 T cells could become regulatory, or is this a feature
of a predetermined lineage (Figure 4)? There is so little
data available to address this that any speculation is
very soft. If a T cell is to be able to suppress, it must lose
its ability to attack, to inflame, and to destroy tissue. Figure 4. Two Models for the Origin of Regulatory/Suppressor T Cells
This may be too difficult a state to impose onto a Th1 There are two main alternative hypotheses for the origin of regulatory
cell but not, perhaps, onto a Th2 T cell or onto naive un- CD41 T cells, and, as we do not yet know whether they represent
a single defined population or are a collection of cell types producedcommitted T cells. It is completely possible that regula-
in response to different immune responses, it is possible that bothtory T cells may turn out to reflect a state (choice model;
are applicable. In the “choices” model, it is postulated that theFigure 4) to which T cells can revert to if aggressive ele-
tolerant and regulatory T cells are an alternative state of activation
ments are controlled. That is why it is now imperative of a naive peripheral T cell that is generated by antigen stimulation
to use the most sophisticated methods to attempt to under conditions of inadequate help or costimulation for an aggres-
“phenotype” clones of regulatory T cells from the differ- sive response. The consequences of this model are that the regula-
tory population will have been antigen experienced and may evenent models to establish their familial relationships, if any.
depend on a continuous source of antigen to maintain the appro-The question of how these T cells regulate is still com-
priate activated state. A further consequence is that there may bepletely open, and, indeed, the literature gives no compel-
hard-to-find stable differentiation markers for defining the regulatoryling frontrunners for mechanisms. The demonstrations
cells, as many will be dependent on the activation state of the cells.
of linked suppression and infectious tolerance teach us The “lineage” model proposes that regulatory T cells are generated
that the effects of regulatory T cells must operate in local during ontogeny within the thymus and are committed only to a
microenvironments (Figure 2) in either central lymphoid suppressive function, although full functional differentiation may still
be dependent on antigen stimulation analogous to regular effectortissue or in the graft itself. Evidence of enrichment of
T cells. In this model, we would expect to find stable expression ofregulators in the graft combined with indicators that
specific differentiation antigens that would enable the population“protective genes” are turned on in tolerated tissues
to be distinguished from other T cells in the thymus and periphery.(Zhai and Kupiec-Weglinski, 1999) suggest that regu-
latory T cells operate at least in part by protecting the
tissues against attack. To take this further, we need
those that ultimately result in dominance of the emergingevidence that cell lines and clones derived from these
new cohort of T-regs. In other words, the process is self-tolerated tissues can confer protection on fresh allo-
sustaining once the graft is in place. Removal of antigengrafts, and we need information on the differential genes
would result in loss of that “chronic stimulus,” and, con-and protein products at these sites.
sequently, infectious tolerance would not occur.We also need to explain infectious tolerance, the pro-
cess by which one set of regulatory T cells encourages
Conclusions and Questions Urgentlydevelopment of further cohorts. At this stage, a sufficient
Needing Answersexplanation could be that, whatever it is that T-regs do
The field of T cell–mediated regulation in transplantationto suppress rejection, they leave the foreign tissue in
is relatively immature in its development. Clearly, thereplace as a source of antigens that can “chronically” stim-
are substantive therapeutic and diagnostic prospectsulate new T cells, which are prevented from rejecting.
that will follow an understanding of mechanisms. In ourThese T cells would then be subject to the same pro-
cesses that “antibody blindfolded” T cells go through— view, the following are the key questions that now need
Review
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of normal rats contain cells with the potential to cause diabetes.answers for the field to continue to make significant prog-
Characterization of the CD41 T cell subset that inhibits this autoim-ress. (1) Are there many mechanisms of suppression
mune potential. J. Exp. Med. 177, 627–636.that are context sensitive, or will there turn out to be a
Graca, L., Honey, K., Adams, E., Cobbold, SP., and Waldmann,common principal mechanism that is then fine tuned in
H. (2000). Cutting edge: anti-CD154 therapeutic antibodies induce
the context of particular tissues? (2) Is regulation or infectious transplantation tolerance. J. Immunol. 165, 4783–4786.
suppression generally a property of a defined lineage
Groux, H., and Powrie, F. (1999). Regulatory T-cells and inflamma-
whose function is only to regulate, or is it a state that tory bowel disease. Immunol. Today 20, 442–445.
many different types of CD41 T cells can acquire (Fig- Groux, H., O’Garra, A., Bigler, M., Rouleau, M., Antonenko, S., de
ure 4)? (3) If T cells can shift their functional state from Vries, J.E., and Roncarolo, M.G. (1997). A CD41 T cell subset inhibits
aggression to regulation, what is the master switch for antigen specific T cell responses and prevents colitis. Nature 389,
737–742.that transition? (4) Are CD81 T cells amenable to such
Hall, B.M. (2000). Mechanisms of induction of tolerance to organinfluences, as indeed they have been implicated in some
allografts. Crit. Rev. Immunol. 20, 267–324.systems of suppression (outside the scope of this re-
Hall, B.M., Jelbart, M.E., Gurley, K.E., and Dorsch, S.E. (1985). Spe-view)? (5) Is suppression mediated centrally (in lymphoid
cific unresponsiveness in rats with prolonged cardiac allograft sur-tissues) or peripherally (in the target tissues) or both?
vival after treatment with cyclosporine. Mediation of specific sup-(6) Is there a way of monitoring whether a therapeutic
pression by T helper/inducer cells. J. Exp. Med. 162, 1683–1694.
maneuver is shifting the system toward operational tol-
Hall, B.M., Pearce, N.W., Gurley, K.E., and Dorsch, S.E. (1990). Spe-erance? This information should come from differential
cific unresponsiveness in rats with prolonged cardiac allograft sur-
gene display and proteomic analysis on clones of regu- vival after treatment with cyclosporine III. Further characterization
latory T cells. of the CD41 suppressor cell and its mechanisms of action. J. Exp.
Med. 171, 141–157.
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